AU2015264025A1 - Micronized Wharton's jelly - Google Patents

Micronized Wharton's jelly Download PDF

Info

Publication number
AU2015264025A1
AU2015264025A1 AU2015264025A AU2015264025A AU2015264025A1 AU 2015264025 A1 AU2015264025 A1 AU 2015264025A1 AU 2015264025 A AU2015264025 A AU 2015264025A AU 2015264025 A AU2015264025 A AU 2015264025A AU 2015264025 A1 AU2015264025 A1 AU 2015264025A1
Authority
AU
Australia
Prior art keywords
jelly
composition
wharton
micronized
micronized wharton
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2015264025A
Other languages
English (en)
Inventor
Somaly SITH
Randall Spencer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mimedx Group Inc
Original Assignee
Mimedx Group Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Mimedx Group Inc filed Critical Mimedx Group Inc
Publication of AU2015264025A1 publication Critical patent/AU2015264025A1/en
Priority to AU2021211985A priority Critical patent/AU2021211985B2/en
Abandoned legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06Animal cells or tissues; Human cells or tissues
    • C12N5/0602Vertebrate cells
    • C12N5/0603Embryonic cells ; Embryoid bodies
    • C12N5/0605Cells from extra-embryonic tissues, e.g. placenta, amnion, yolk sac, Wharton's jelly
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/51Umbilical cord; Umbilical cord blood; Umbilical stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48Reproductive organs
    • A61K35/50Placenta; Placental stem cells; Amniotic fluid; Amnion; Amniotic stem cells
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61LMETHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L27/00Materials for grafts or prostheses or for coating grafts or prostheses
    • A61L27/36Materials for grafts or prostheses or for coating grafts or prostheses containing ingredients of undetermined constitution or reaction products thereof, e.g. transplant tissue, natural bone, extracellular matrix
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2509/00Methods for the dissociation of cells, e.g. specific use of enzymes
    • C12N2509/10Mechanical dissociation

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Reproductive Health (AREA)
  • Organic Chemistry (AREA)
  • Dermatology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Pregnancy & Childbirth (AREA)
  • Virology (AREA)
  • General Engineering & Computer Science (AREA)
  • Botany (AREA)
  • Transplantation (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Hematology (AREA)
  • Rheumatology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU2015264025A 2014-05-21 2015-05-21 Micronized Wharton's jelly Abandoned AU2015264025A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2021211985A AU2021211985B2 (en) 2014-05-21 2021-08-02 Micronized Wharton's jelly

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201462001600P 2014-05-21 2014-05-21
US62/001,600 2014-05-21
PCT/US2015/032078 WO2015179711A1 (en) 2014-05-21 2015-05-21 Micronized wharton's jelly

Related Child Applications (1)

Application Number Title Priority Date Filing Date
AU2021211985A Division AU2021211985B2 (en) 2014-05-21 2021-08-02 Micronized Wharton's jelly

Publications (1)

Publication Number Publication Date
AU2015264025A1 true AU2015264025A1 (en) 2016-12-01

Family

ID=54554801

Family Applications (2)

Application Number Title Priority Date Filing Date
AU2015264025A Abandoned AU2015264025A1 (en) 2014-05-21 2015-05-21 Micronized Wharton's jelly
AU2021211985A Active AU2021211985B2 (en) 2014-05-21 2021-08-02 Micronized Wharton's jelly

Family Applications After (1)

Application Number Title Priority Date Filing Date
AU2021211985A Active AU2021211985B2 (en) 2014-05-21 2021-08-02 Micronized Wharton's jelly

Country Status (5)

Country Link
US (1) US20150335686A1 (enExample)
EP (1) EP3146039A4 (enExample)
JP (2) JP2017517255A (enExample)
AU (2) AU2015264025A1 (enExample)
WO (1) WO2015179711A1 (enExample)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8182841B2 (en) 2005-09-27 2012-05-22 Tissue Tech, Inc. Amniotic membrane preparations and purified compositions and anti-inflammation methods
WO2012149486A1 (en) 2011-04-28 2012-11-01 Tissuetech, Inc. Methods of modulating bone remodeling
WO2012170905A1 (en) 2011-06-10 2012-12-13 Tissuetech, Inc. Methods of processing fetal support tissues, fetal support tissue powder products, and uses thereof
TW201603818A (zh) 2014-06-03 2016-02-01 組織科技股份有限公司 組成物及方法
WO2016007554A1 (en) * 2014-07-08 2016-01-14 Mimedx Group, Inc. Micronized wharton's jelly
US10201573B1 (en) * 2014-10-27 2019-02-12 Brahm Holdings, Llc Human birth tissue material composition and methods for the treatment of damage associated with a cerebral vascular accident
WO2016138025A2 (en) 2015-02-23 2016-09-01 Tissuetech, Inc. Apparatuses and methods for treating ophthalmic diseases and disorders
JP2018516869A (ja) 2015-05-20 2018-06-28 ティッシュテック,インク. 上皮細胞の増殖および上皮間葉転換を防ぐための組成物および方法
US10420802B2 (en) 2015-12-10 2019-09-24 Aesthetics Biomedical, Inc. Topical formulation for skin care
TW201733600A (zh) 2016-01-29 2017-10-01 帝聖工業公司 胎兒扶持組織物及使用方法
CA3050082A1 (en) 2016-04-04 2017-10-12 Omeza LLC Fish oil topical composition
WO2017223494A1 (en) * 2016-06-24 2017-12-28 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
FR3070262B1 (fr) 2017-08-23 2020-10-16 Tbf Genie Tissulaire Tbf Composition comprenant de la gelee de wharton, procede de preparation et utilisations
US10251917B1 (en) 2017-09-19 2019-04-09 Gary M. Petrucci Methods and materials for treating tumors
CA3076485A1 (en) * 2017-09-19 2019-03-28 Gary M. Petrucci Amnion tissue preparations and methods of using
US11246994B2 (en) 2017-10-19 2022-02-15 Lifecell Corporation Methods for introduction of flowable acellular tissue matrix products into a hand
ES2960617T3 (es) * 2017-10-19 2024-03-05 Lifecell Corp Productos de matriz de tejido acelular fluida y métodos de producción
JP2022543362A (ja) * 2019-08-08 2022-10-12 ティシュー リジェネレイション セラピューティックス、インコーポレイテッド 血管周囲溶解物及びその使用
WO2021183851A1 (en) * 2020-03-12 2021-09-16 Osiris Therapeutics, Inc. Human tissue derived compositions and uses thereof
US11844876B2 (en) 2021-01-25 2023-12-19 BioStem Tehcnologies, Inc. Two-part clotting composition and methods of making and using thereof
CA3255906A1 (en) * 2022-04-20 2023-10-26 Biostem Technologies, Inc. Human amniotic composition processed in several parts and its processes of manufacture and use for the treatment of Peyronie's disease
EP4561595A2 (en) * 2022-07-26 2025-06-04 Biostem Technologies, Inc. Human umbilical cord compositions and methods for intra-articular therapy
US20240226181A1 (en) * 2023-01-11 2024-07-11 Biostem Technologies, Inc. Human umbilical cord composition for treatment of peyronie's disease

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2453638A1 (fr) * 1979-04-10 1980-11-07 Bontemps Raymond Produits cosmetiques exempts de tout excipient et de tout conservateur et applicables a l'etat congele
US20060074182A1 (en) * 2004-09-30 2006-04-06 Depuy Products, Inc. Hydrogel composition and methods for making the same
US9005646B2 (en) * 2005-10-12 2015-04-14 Lifenet Health Compositions for repair of defects in tissues, and methods of making the same
US8105634B2 (en) * 2006-08-15 2012-01-31 Anthrogenesis Corporation Umbilical cord biomaterial for medical use
US8071135B2 (en) * 2006-10-04 2011-12-06 Anthrogenesis Corporation Placental tissue compositions
BRPI0822802A2 (pt) * 2008-10-10 2015-09-01 Histocell Sl Biomaterial na forma de hidrogel injetável, biomaterial derivado do cordão umbilical humano, processo para a obtenção do biomaterial, processo para a obtenção do biomaterial obtido e uso do biomaterial
CN102198292B (zh) * 2010-03-26 2013-06-26 卢世璧 组织工程用脐带去细胞Wharton胶支架及其制备方法
JP5591995B2 (ja) * 2010-03-30 2014-09-17 イストセル,エセ.エレ. ウォートンジェリー臍帯由来の新規の生体材料
CA2826433C (en) * 2011-02-14 2022-05-31 Brenda S. Morse Micronized placental tissue compositions and methods of making and using the same
WO2012112410A2 (en) * 2011-02-14 2012-08-23 Mimedx Group Inc. Micronized placental tissue compositions and methods for making and using the same
US12290613B2 (en) * 2011-10-06 2025-05-06 Mimedx Group, Inc. Micronized compositions composed of bone grafts and methods of making and using the same
WO2013102219A1 (en) * 2011-12-30 2013-07-04 Amit Patel Methods and compositions for the clinical derivation of an allogenic cell and therapeutic uses
EP2884944B1 (en) * 2012-08-15 2020-10-07 MiMedx Group, Inc. Reinforced placental tissue grafts and methods of making and using the same
US11338063B2 (en) * 2012-08-15 2022-05-24 Mimedx Group, Inc. Placental tissue grafts modified with a cross-linking agent and methods of making and using the same
US8904664B2 (en) * 2012-08-15 2014-12-09 Mimedx Group, Inc. Dehydration device and methods for drying biological materials
US9943551B2 (en) * 2012-08-15 2018-04-17 Mimedx Group, Inc. Tissue grafts composed of micronized placental tissue and methods of making and using the same
US20150086634A1 (en) * 2013-09-10 2015-03-26 Mimedx Group, Inc. Cosmetic uses of molded placental compositions

Also Published As

Publication number Publication date
EP3146039A4 (en) 2017-11-29
AU2021211985A1 (en) 2021-08-26
JP2017517255A (ja) 2017-06-29
JP7304316B2 (ja) 2023-07-06
AU2021211985B2 (en) 2023-06-01
EP3146039A1 (en) 2017-03-29
US20150335686A1 (en) 2015-11-26
WO2015179711A1 (en) 2015-11-26
JP2020143150A (ja) 2020-09-10

Similar Documents

Publication Publication Date Title
AU2021211985B2 (en) Micronized Wharton's jelly
US10307443B2 (en) Micronized wharton's jelly
JP7749620B2 (ja) コラーゲンおよび微粉化胎盤組織からなる組成物ならびにその調製および使用方法
US20180221418A1 (en) Micronized placental tissue compositions and methods of making and using the same
EP3191145B1 (en) Micronized placental tissue compositions
AU2019272042A1 (en) Micronized placental tissue compositions and methods of making and using the same
US12076348B2 (en) Micronized placental compositions comprising a chelator

Legal Events

Date Code Title Description
MK5 Application lapsed section 142(2)(e) - patent request and compl. specification not accepted